Triple
T22796800
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | LOXO-195 |
E564270
|
entity |
| Predicate | hasAlternativeName |
P39
|
FINISHED |
| Object | BAY 2731954 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: BAY 2731954 | Statement: [LOXO-195, hasAlternativeName, BAY 2731954]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: BAY 2731954 Context triple: [LOXO-195, hasAlternativeName, BAY 2731954]
-
A.
TAK-079
TAK-079 is an investigational human monoclonal antibody designed to deplete CD38-expressing cells, primarily being developed for the treatment of multiple myeloma and certain autoimmune diseases.
-
B.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
-
C.
GS-5734
GS-5734, better known by its generic name remdesivir, is a broad-spectrum antiviral medication used to treat infections such as COVID-19.
-
D.
Tasigna
Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
-
E.
Vilapicina
Vilapicina is a Barcelona Metro station in the Horta-Guinardó district that serves as part of the city's Line 5 network.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: BAY 2731954 Target entity description: BAY 2731954 is a highly selective small-molecule inhibitor of TRK kinases developed as a targeted therapy for cancers driven by NTRK gene fusions.
-
A.
TAK-079
TAK-079 is an investigational human monoclonal antibody designed to deplete CD38-expressing cells, primarily being developed for the treatment of multiple myeloma and certain autoimmune diseases.
-
B.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
-
C.
GS-5734
GS-5734, better known by its generic name remdesivir, is a broad-spectrum antiviral medication used to treat infections such as COVID-19.
-
D.
Tasigna
Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
-
E.
Vilapicina
Vilapicina is a Barcelona Metro station in the Horta-Guinardó district that serves as part of the city's Line 5 network.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2458185f88190b0045227ee420411 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17cd9b3c0819096050f43a829ec0d |
completed | April 29, 2026, 3:36 a.m. |
Created at: April 17, 2026, 3:30 p.m.